Breaking News Instant updates and real-time market news.

BOLD

Audentes Therapeutics

$36.69

0.34 (0.94%)

16:29
10/09/18
10/09
16:29
10/09/18
16:29

Audentes Therapeutics initiated with a Neutral at Guggenheim

Guggenheim analyst Whitney Ijem initiated Audentes Therapeutics with a Neutral rating, saying that at current levels they believe the potential revenues are already reflected.

  • 09

    Oct

BOLD Audentes Therapeutics
$36.69

0.34 (0.94%)

10/09/18
GUGG
10/09/18
INITIATION
GUGG
Neutral
Audentes Therapeutics initiated with a Neutral at Guggenheim
10/08/18
MZHO
10/08/18
NO CHANGE
Target $45
MZHO
Buy
Audentes data met best-case scenario, says Mizuho
Mizuho analyst Difei Yang says the Phase 1/2 clinical trial of AT132 for the treatment of XLMTM reported Friday by Audentes Therapeutics were "impressive" and met her best-case scenario expectations. Cohort one patients showing continued improvements out to week 48 and the initial cohort two patient showing rapid initial improvement at week four, Yang tells investors in a research note. Further, the safety profile remains "highly encouraging" and discussions with regulators are expected to begin in Q4, the analyst adds. She reiterates a Buy rating on Audentes with a $45 price target.
10/05/18
PIPR
10/05/18
NO CHANGE
PIPR
Overweight
Piper remain buyers of Audentes after update on AT132
Piper Jaffray analyst Christopher Raymond said he remains a buyer of Audentes Therapeutics after the company announced new interim data from ASPIRO, the Phase 1/2 clinical trial of AT132 for the treatment of X-linked Myotubular Myopathy. Significant improvements in respiratory function continued for all patients in Cohort 1 and across the board CHOP-INTEND scores tended to improve for most patients, Raymond tells investors. The analyst, who thinks the XLMTM program has become "increasingly derisked," maintains an Overweight rating on Audentes shares.
10/04/18
PIPR
10/04/18
NO CHANGE
Target $45
PIPR
Overweight
Piper sees much larger market potential for Audentes' AT132
A recent article in Neuromuscular Disorders suggests that the global incidence and prevalence of X-linked myotubular myopathy and other centronuclear myopathies may be much higher than previously thought, Piper Jaffray analyst Christopher Raymond tells investors in a research note. The analyst says that due to advancements in diagnostic approaches that can identify patients with milder disease and updated patient survival estimates, the pool of patients eligible for Audentes Therapeutics ' AT132 treatment may be three-times greater than he currently models. He notes that AT132 represents $13 per share in his sum-of-parts analysis and that this would increase with higher XLMTM incidence and prevalence assumptions. Raymond continues to like the setup for the the stock and keeps an Overweight rating on Audentes Therapeutics with a $45 price target.

TODAY'S FREE FLY STORIES

SPN

Superior Energy

$4.43

0.165 (3.87%)

16:53
02/18/19
02/18
16:53
02/18/19
16:53
Earnings
Superior Energy reports Q4 EPS ($4.85), may not compare consensus (0.28c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

MSG

Madison Square Garden

$291.37

0.85 (0.29%)

16:46
02/18/19
02/18
16:46
02/18/19
16:46
Periodicals
MSG denies Knicks sale talks after Bill Simmons claims otherwise »

Madison Square Garden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

16:45
02/18/19
02/18
16:45
02/18/19
16:45
Hot Stocks
Windstream postpones release of Q4, FY18 financial results »

Windstream announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

UFPI

Universal Forest

$32.22

0.36 (1.13%)

16:43
02/18/19
02/18
16:43
02/18/19
16:43
Hot Stocks
Universal Forest signs agreement to acquire Wolverine Wood Products »

Universal Forest Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SCI

Service Corp.

$45.96

0.56 (1.23%)

16:36
02/18/19
02/18
16:36
02/18/19
16:36
Earnings
Breaking Earnings news story on Service Corp. »

Service Corp. sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

SCI

Service Corp.

$45.96

0.56 (1.23%)

16:34
02/18/19
02/18
16:34
02/18/19
16:34
Earnings
Service Corp. reports Q4 adjusted EPS 54c, consensus 56c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

APY

Apergy

$36.84

0.92 (2.56%)

16:27
02/18/19
02/18
16:27
02/18/19
16:27
Earnings
Apergy reports Q4 adjusted EPS 36c, consensus 33c »

Reports Q4 revenue of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NAVI

Navient

$11.75

0.12 (1.03%)

16:20
02/18/19
02/18
16:20
02/18/19
16:20
Hot Stocks
Navient rejects highly conditional unsolicited 'expression of interest' »

Navient announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLCA

U.S. Silica

$14.41

-0.005 (-0.03%)

16:15
02/18/19
02/18
16:15
02/18/19
16:15
Hot Stocks
24 SandBox Logistics patent claims invalidated »

Proppant Express…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 28

    May

JBHT

J.B. Hunt

$113.78

1.66 (1.48%)

16:12
02/18/19
02/18
16:12
02/18/19
16:12
Hot Stocks
J.B. Hunt completes acquisition of Cory 1st Choice Home Delivery »

J.B. Hunt announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 06

    Mar

CAT

Caterpillar

$136.21

3.575 (2.70%)

16:10
02/18/19
02/18
16:10
02/18/19
16:10
Hot Stocks
Caterpillar announces several officer moves »

Caterpillar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

CUB

Cubic

$60.35

2.995 (5.22%)

16:07
02/18/19
02/18
16:07
02/18/19
16:07
Hot Stocks
Cubic announces semiannual dividend of 13.5c per share »

Cubic announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 19

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

HMC

Honda

$27.35

0.04 (0.15%)

13:11
02/18/19
02/18
13:11
02/18/19
13:11
Periodicals
Honda plan to close U.K. plant not due to Brexit, Reuters reports »

Honda plans to shut its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$27.35

0.04 (0.15%)

13:07
02/18/19
02/18
13:07
02/18/19
13:07
Periodicals
Honda to close U.K. car plant in 2022, Reuters reports »

Honda is set to announce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUNMF

Lundin Mining

$0.00

(0.00%)

13:04
02/18/19
02/18
13:04
02/18/19
13:04
Downgrade
Lundin Mining rating change at Goldman Sachs »

Lundin Mining downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVR

Chicago Rivet & Machine

$28.36

0.56 (2.01%)

12:38
02/18/19
02/18
12:38
02/18/19
12:38
Hot Stocks
Chicago Rivet & Machine announces increase in quarterly cash dividend to 22c »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$87.77

2.27 (2.66%)

, XRX

Xerox

$30.46

0.63 (2.11%)

12:36
02/18/19
02/18
12:36
02/18/19
12:36
Hot Stocks
Quest Diagnostics names Gabrielle Wolfson senior VP, CIO »

Quest Diagnostics (DGX)…

DGX

Quest Diagnostics

$87.77

2.27 (2.66%)

XRX

Xerox

$30.46

0.63 (2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRDX

Surmodics

$56.79

3.09 (5.75%)

12:29
02/18/19
02/18
12:29
02/18/19
12:29
Hot Stocks
Surmodics announces appointment of Timothy Arens as CFO »

Surmodics announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

CUB

Cubic

$60.35

2.995 (5.22%)

, IBM

IBM

$138.05

1.55 (1.14%)

12:28
02/18/19
02/18
12:28
02/18/19
12:28
Hot Stocks
Cubic names IBM, Microsoft executive Kevin Eagan as Senior VP, Chief Digital »

Cubic (CUB) announced the…

CUB

Cubic

$60.35

2.995 (5.22%)

IBM

IBM

$138.05

1.55 (1.14%)

MSFT

Microsoft

$108.19

1.35 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 19

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 18

    Mar

CGUSY

Casino Guichard Perrachon

$0.00

(0.00%)

11:50
02/18/19
02/18
11:50
02/18/19
11:50
Downgrade
Casino Guichard Perrachon rating change at Deutsche Bank »

Casino Guichard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPYYY

Centrica

$0.00

(0.00%)

11:46
02/18/19
02/18
11:46
02/18/19
11:46
Downgrade
Centrica rating change at Berenberg »

Centrica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
02/18/19
02/18
11:15
02/18/19
11:15
General news
FX Summary: AUD-JPY has been the biggest mover »

FX Summary: AUD-JPY has…

MSM

MSC Industrial

$86.24

0.81 (0.95%)

11:07
02/18/19
02/18
11:07
02/18/19
11:07
Hot Stocks
MSC Industrial reports patent issued for cost-savings documentation system »

As previously reported on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

08:35
02/18/19
02/18
08:35
02/18/19
08:35
General news
Oil Action: Front-month WTI crude futures are up 1.0% »

Oil Action: Front-month…

07:00
02/18/19
02/18
07:00
02/18/19
07:00
General news
FX Update: A Dollar softening theme took hold during the London AM session »

FX Update: A Dollar…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.